321 related articles for article (PubMed ID: 15890115)
1. Risk factors for kala-azar in Bangladesh.
Bern C; Hightower AW; Chowdhury R; Ali M; Amann J; Wagatsuma Y; Haque R; Kurkjian K; Vaz LE; Begum M; Akter T; Cetre-Sossah CB; Ahluwalia IB; Dotson E; Secor WE; Breiman RF; Maguire JH
Emerg Infect Dis; 2005 May; 11(5):655-62. PubMed ID: 15890115
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village.
Bern C; Haque R; Chowdhury R; Ali M; Kurkjian KM; Vaz L; Amann J; Wahed MA; Wagatsuma Y; Breiman RF; Williamson J; Secor WE; Maguire JH
Am J Trop Med Hyg; 2007 May; 76(5):909-14. PubMed ID: 17488915
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for Indian kala-azar.
Ranjan A; Sur D; Singh VP; Siddique NA; Manna B; Lal CS; Sinha PK; Kishore K; Bhattacharya SK
Am J Trop Med Hyg; 2005 Jul; 73(1):74-8. PubMed ID: 16014837
[TBL] [Abstract][Full Text] [Related]
4. Increasing incidence of post-kala-azar dermal leishmaniasis in a population-based study in Bangladesh.
Rahman KM; Islam S; Rahman MW; Kenah E; Ghalib CM; Zahid MM; Maguire J; Rahman M; Haque R; Luby SP; Bern C
Clin Infect Dis; 2010 Jan; 50(1):73-6. PubMed ID: 19951168
[TBL] [Abstract][Full Text] [Related]
5. Kala-azar epidemic in Varanasi district, India.
Kumar R; Kumar P; Chowdhary RK; Pai K; Mishra CP; Kumar K; Pandey HP; Singh VP; Sundar S
Bull World Health Organ; 1999; 77(5):371-4. PubMed ID: 10361752
[TBL] [Abstract][Full Text] [Related]
6. Visceral leishmaniasis: consequences to women in a Bangladeshi community.
Ahluwalia IB; Bern C; Wagatsuma Y; Costa C; Chowdhury R; Ali M; Amann J; Haque R; Breiman R; Maguire JH
J Womens Health (Larchmt); 2004 May; 13(4):360-4. PubMed ID: 15186651
[TBL] [Abstract][Full Text] [Related]
7. Present situation of vector-control management in Bangladesh: a wake up call.
Mondal D; Alam MS; Karim Z; Haque R; Boelaert M; Kroeger A
Health Policy; 2008 Sep; 87(3):369-76. PubMed ID: 18342389
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology of visceral leishmaniasis in Bangladesh: prospects for improved control.
Bern C; Chowdhury R
Indian J Med Res; 2006 Mar; 123(3):275-88. PubMed ID: 16778310
[TBL] [Abstract][Full Text] [Related]
9. Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors.
Schenkel K; Rijal S; Koirala S; Koirala S; Vanlerberghe V; Van der Stuyft P; Gramiccia M; Boelaert M
Trop Med Int Health; 2006 Dec; 11(12):1792-9. PubMed ID: 17176343
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of visceral leishmaniasis associated with the behaviors of the people in rural areas.
Shah H
JNMA J Nepal Med Assoc; 2005; 44(160):116-20. PubMed ID: 16751812
[TBL] [Abstract][Full Text] [Related]
11. Seroepidemiological study on kala-azar in Baringo District, Kenya.
Jahn A; Lelmett JM; Diesfeld HJ
J Trop Med Hyg; 1986 Apr; 89(2):91-104. PubMed ID: 3021967
[TBL] [Abstract][Full Text] [Related]
12. The effect of age and sex on incidence of kala-azar.
Sharma MC; Gupta AK; Saran R; Sinha SP
J Commun Dis; 1990 Dec; 22(4):277-8. PubMed ID: 2098434
[TBL] [Abstract][Full Text] [Related]
13. Visceral leishmaniasis: consequences of a neglected disease in a Bangladeshi community.
Ahluwalia IB; Bern C; Costa C; Akter T; Chowdhury R; Ali M; Alam D; Kenah E; Amann J; Islam M; Wagatsuma Y; Haque R; Breiman RF; Maguire JH
Am J Trop Med Hyg; 2003 Dec; 69(6):624-8. PubMed ID: 14740879
[TBL] [Abstract][Full Text] [Related]
14. Visceral leishmaniasis is preventable in a highly endemic village in West Bengal, India.
Saha S; Ramachandran R; Hutin YJ; Gupte MD
Trans R Soc Trop Med Hyg; 2009 Jul; 103(7):737-42. PubMed ID: 19036393
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of visceral leishmaniasis in India.
Bora D
Natl Med J India; 1999; 12(2):62-8. PubMed ID: 10416321
[TBL] [Abstract][Full Text] [Related]
16. Resurgence of visceral leishmaniasis in Bangladesh.
Rahman KM; Islam N
Bull World Health Organ; 1983; 61(1):113-6. PubMed ID: 6601534
[TBL] [Abstract][Full Text] [Related]
17. Clinicoepidemiological profile of kala azar patients in Delhi.
Mittal V; Bhatia R; Sehgal S
J Commun Dis; 1989 Dec; 21(4):255-61. PubMed ID: 2638373
[TBL] [Abstract][Full Text] [Related]
18. Loss of leishmanin skin test antigen sensitivity and potency in a longitudinal study of visceral leishmaniasis in Bangladesh.
Bern C; Amann J; Haque R; Chowdhury R; Ali M; Kurkjian KM; Vaz L; Wagatsuma Y; Breiman RF; Secor WE; Maguire JH
Am J Trop Med Hyg; 2006 Oct; 75(4):744-8. PubMed ID: 17038705
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological study of kala-azar by direct agglutination test in two rural communities of eastern Nepal.
Koirala S; Karki P; Das ML; Parija SC; Karki BM
Trop Med Int Health; 2004 Apr; 9(4):533-7. PubMed ID: 15078273
[TBL] [Abstract][Full Text] [Related]
20. Changes in age incidence of kala-azar in India.
Basu D; Mallik KK
Indian J Public Health; 1995; 39(1):26. PubMed ID: 8690477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
